Top Back to top

ANBI Data

Full name of the Institution

The European Society for Blood and Marrow Transplantation 

Tax identification numbers

RSIN Foundation: 814370822
RSIN Association: 804217257

Contact details in The Netherlands

Rijnsburgerweg 10, 2333 AA. Leiden, The Netherlands
email: info@ebmt.org
phone number: +31 71 526 1444  

Board Composition

The Executive Committee:
  • President: Mohamad Mohty
  • Secretary: Rafael Duarte
  • Treasurer: Jürgen Kuball

Chair of the Scientific Council: Nicolaus Kröger 
Co-Chair of the Scientific Council: Arnon Nagler 
Educational Representative of the Scientific Council: Carlo Dufour 
Registry Representative of the Scientific Council: Chiara Bonini 
President of the Nurses Group: John Murray 
EBMT Congress President: Manuel Abecasis

The policy and remuneration policy

The Board is the administrative body of the EBMT. It is responsible for all running operations and decisions that are not due to be taken by the General Assembly (see below). The Board consists of the President, the President-Elect, the Secretary, the Treasurer, the President of the division EBMT Nurses Group and four members elected by and from the Scientific Council. The President of the forthcoming EBMT Annual Meeting is elected onto the Board for the year preceding the annual meeting as a non-voting member. Decisions are taken by majority voting. The President has the deciding vote if the vote is otherwise tied. The Members of the Board will receive no remuneration for their work, unless the Genera Assembly Meeting decides otherwise at the time of appointment. Any expenses incurred will be reimbursed in consultation with the Board.
 
Please refer to the EBMT Foundation Constitution and EBMT Association Constitution and EBMT bylaws to more details on the EBMT Policy.

The Target

The target of the EBMT is well defined in the association’s Mission and Vision:

Our Mission:

To save lives of patients with blood cancers and other life-threatening diseases by advancing the fields of blood and marrow transplantation and cell therapy worldwide through science, education and advocacy.

Our Vision:
  • Enhancing the scientific output of the organisation through strong support for the working parties activities to exploit the potential of the registry, and continue generating high quality retrospective and prospective data both in the autologous and allogeneic settings;
  • Collaborating with the different disease-oriented cooperative groups
  • Widening the scope of the Annual Meeting through the incorporation of high level basic and translational research sessions
  • Developing a broad annual education and events agenda in order to address more focused research and clinical trials
  • Advocating for patients before the health authorities in order to maintain a high standard of care and high quality research

Report of our activities and financial report

For this information, please refer to the Annual Report​.

Need help?

The personal data provided will be processed according to the General Data Protection Regulation (GDPR 2016/679 ) and incorporated to a file property of EBMT which will be allocated in the EEA (European Economic Area) or in countries that are provided with the same level of protection for privacy such as countries that adhere to EU-US and Swiss-US Privacy Shield Frameworks.
Data Subjects have the right of access to his or her data and the right to rectification of any inaccurate or incomplete personal data. The Data Subject also has the right to withdraw consent, this wish will be respected, and the personal will no longer be made available. If the processing operation is unlawful the Data Subject has the right to request deletion of that data. Please write to data.protection@ebmt.org